|
Englewood Hospital and Medical Center
Englewood, New Jersey
Saturday, March 13, 2004
The primary purpose of the Update 2004 program jointly hosted by the SynCure Cancer Research Foundation and Englewood Hospital and Medical Center was to provide a substantive educational program on advancements in cancer research and treatment for cancer patients, their friends and family, the health care/support community, and the general public. By all accounts, the symposium was a tremendous success. There were 237 registrants and an audience of approximately 150.
This program was made possible at no cost to the public by the support of our corporate sponsors:
Gold Sponsor:
Biogen Idec
Silver Sponsors:
Amgen, AstraZeneca, GlaxoSmithKline, Novartis Nutrition, Ortho Biotech
Agenda
| Welcome & Introduction |
Margaret Bridge |
Englewood Hospital |
|
Stephen S. Roman |
SynCure Cancer Research Foundation |
| The Role of NCI in the War on Cancer |
J. Carl Barrett, Ph.D. |
National Cancer Institute |
| The Critical Role of Clinical Trials |
Jill S. Morrison, M.D. |
Englewood Hospital |
| Innovations in Radiation Oncology |
Mei M. Zhang, M.D. |
Englewood Hospital |
| Break |
|
|
| Advances in Immunotherapy |
Jedd D. Wolchok, M.D. |
Memorial Sloan-Kettering Cancer Center |
| Technical Advances in Urologic Oncology |
Richard Lee, M.D. |
Englewood Hospital |
| Luncheon |
|
|
| New Generation Targeted Drugs |
Leonard J. Appleman, M.D. |
Harvard/Dana Farber Cancer Institute |
| Question and Answer Panel Discussion |
Moderator, Jill Morrison, M.D. |
|
|
|
|
Attendees Comments
2) The program was excellent. It provided much needed information and also educated me about what is being done in research. It was great to have an opportunity to hear and question doctors in the field of cancer research and treatment.
3) Very good. Very informative and presented in such a way that the average person could understand.
4) One of the best I've been to. Very well prepared.
5) Absolutely phenominal! Please do this type of program more often.
6) Excellent speakers-most infomative and appreciated. As there are new developments in the cancer field, these updates are so important. Thank you!
7) Very informative. Well organized. Speakers were very knowledgeable. The program was very much more than expected and well worth the time I spent getting here from New York. SynCure is doing a great job!
8) The program was well organized; the speakers were absolutely wonderful and spoke in laymen's terms. I learned quite a lot from this program. I do hope you have more programs like this one in the future.
Speakers
Leonard J. Appleman, M.D.
Adult Oncology
Harvard/Dana-Farber Cancer Institute
Boston, MA
|
|
Dr. Appleman received his M.D. and Ph.D. degrees from New York University in 1995. He completed medical residency at the Beth Israel Hospital (Boston) in 1998. In 2001 he completed a fellowship in Oncology/Hematology at the Dana-Farber/Partners CancerCare program in Boston. His clinical interests are Phase I trials and renal cell carcinoma, while his research interests include cell cycle regulation and development of phamacodynamic assays.
|
J. Carl Barrett, Ph.D.
Director, Center for Cancer Research
National Cancer Institute
Bethesda, MD
|
|
Dr. Barrett is the Director of the Center for Cancer Research (CCR) of the National Cancer Institute. The CCR is the largest basic and clinical cancer research facility in the world with approximately 3,500 employees. In addition to leading this cancer research organization, Dr. Barrett is a prolific researcher himself with over 480 scientific publications spanning his 30-year career. Prior to joining the NCI, he was with the National Institute of Environmental Health Sciences in North Carolina for 23 years. He received a B.S degree in Chemistry from William and Mary and a Ph.D. in Biophysical Chemistry from Johns Hopkins University.
|
Richard Lee, M.D.
Physician
Englewood Hospital & Medical Center
Englewood, NJ
|
|
Dr. Lee graduated with honors from Cornell University in Chemistry, and he then went on to medical school at Mount Sinai/New York University School of Medicine in 1995. He remained at Mount Sinai Hospital in New York for both his internship in surgery and his urologic training. He has experience in both adult and pediatric urology including the most up to date oncologic care. Dr. Lee was trained in advanced laparoscopic techniques and endoscopic procedures and is certified by the American Board of Urology. He is fluent in Spanish and Chinese.
|
Jill Morrison, M.D.
Physician
Englewood Hospital & Medical Center
Englewood, NJ
|
|
Hematologist/ Oncologist Jill S. Morrison, M.D., earned her M.D. at Boston University School of Medicine. She completed her internship and residency at Mount Sinai Hospital. At New York Hospital-Cornell University Medical College, Dr. Morrison was a College Protocol Fellow, a James Dublin Fellow, a Clinical Fellow and Chief Fellow. She has been a hematologist/oncologist at Englewood Hospital and Medical Center since 1997 with a special interest in clinical trials.
|
Jedd Wolchok, M.D., Ph.D.
Assistant Attending Physician, Clinical Immunology Service
Memorial Sloan-Kettering Cancer Center
New York, NY
|
|
Dr. Wolchok is a member of the faculty of Memorial Sloan-Kettering Cancer Center with expertise in the treatment of metastatic melanoma. His specific research interest is novel immunologic therapies and he has been involved in the development of the DNA vaccine program at every level, from pre-clinical studies in mouse models through clinical trials. Dr. Wolchok has authored numerous articles concerning DNA vaccines and clinical care of melanoma, and he co-authored two chapters in the definitive textbook, Cutaneous Melanoma. Dr. Wolchok received his advanced education at New York University where he earned an M.D. as well as a Ph.D. in microbiology.
|
|
Mei Zhang, M.D.
Physician
Englewood Hospital & Medical Center
Englewood, NJ
|
|
Radiation Oncologist Mei Zhang, M.D. earned her M.D. at Shanghai Second Medical University, Shanghai China. She completed a Doctor of Pharmacy degree from the University of Nebraska Medical Center, Omaha Nebraska, and interned in Internal Medicine at MCP-Hahnemann University Hospital, Philadelphia, where she also completed her residency in Radiation Oncology. Dr. Zhang is involved in ongoing research to study different radiotherapy techniques for the treatment of pancreatic cancer. Dr. Zhang has treated numerous patients at Englewood Hospital for a variety of illness and is particularly interested in the field of breast cancer.
|
Participating Organizations
- Astra Zeneca
- Leukemia and Lymphoma Society
|
- Mead Johnson
- Gilda's Club
|
|
